Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (11): 697-698.
DOI: 10.19803/j.1672-8629.2019.11.12
Previous Articles Next Articles
ZHAO Na1, LIU Wei1, BAI Xiafeng2
Received:2019-11-27
Revised:2019-11-27
Online:2019-11-20
Published:2019-11-27
CLC Number:
ZHAO Na, LIU Wei, BAI Xiafeng. One Case of Erythrodermic Drug Eruption Induced by Meropenem for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(11): 697-698.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.11.12
| [1] 赵辨. 临床皮肤病学[M]. 3版.南京:江苏科学技术出版社, 2001, 754-755. [2] 高彬,陈德宇.红皮病治疗进展[J].西南军医, 2009,11(5):933-935. [3] 王光华,王子惠,张莹,等.阿莫西林舒巴坦致红皮病型药疹1例[J].中国药业, 2016, 25(12):96-97. [4] 冯立红,丁雪梅,刘治军.1 例肺脓肿患者抗感染治疗引发红皮病型药疹的病例讨论[J].中国新药杂志, 2011, 20(16):1583-1586. [5] 谢本树. 新型碳青霉烯类抗生素美罗培南的临床应用研究进展[J].中国药房, 2011, 22(5):456. [6] 李瑞. 药理学[M].6版,北京:人民卫生出版社, 2008:412-413. [7] 吴健,高家荣,李颖,等. 142例美罗培南临床应用分析研究[J].中国药物警戒, 2013, 10(4):249-251. [8] 官东秀,冯祚臻,俸小平,等.美罗培南的药品不良反应文献分析[J].中国医院用药评价与分析, 2009, 9(5):397. [9] 陈彬. 静脉输入美罗培南致全身剥脱性皮炎及器官衰竭死亡1例[J].护理研究, 2010, 24(4):933-934. [10] 鲍妍,崔英春,孔丽丽,等.美罗培南致迟发性剥脱性皮炎1例[J].中国实验诊断学, 2013, 17(7):1339-1340. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
